JP2013531048A5 - - Google Patents

Download PDF

Info

Publication number
JP2013531048A5
JP2013531048A5 JP2013520068A JP2013520068A JP2013531048A5 JP 2013531048 A5 JP2013531048 A5 JP 2013531048A5 JP 2013520068 A JP2013520068 A JP 2013520068A JP 2013520068 A JP2013520068 A JP 2013520068A JP 2013531048 A5 JP2013531048 A5 JP 2013531048A5
Authority
JP
Japan
Prior art keywords
general formula
pharmaceutical composition
pharmacologically active
siloxane
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013520068A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013531048A (ja
Filing date
Publication date
Priority claimed from EP10007536A external-priority patent/EP2409702A1/en
Application filed filed Critical
Publication of JP2013531048A publication Critical patent/JP2013531048A/ja
Publication of JP2013531048A5 publication Critical patent/JP2013531048A5/ja
Pending legal-status Critical Current

Links

JP2013520068A 2010-07-21 2011-07-13 歯牙障害を治療するためのシロキサンおよび活性成分の組合せ Pending JP2013531048A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10007536.5 2010-07-21
EP10007536A EP2409702A1 (en) 2010-07-21 2010-07-21 Combination of siloxane and active ingredient for treating dental disorder of hard tissues
PCT/EP2011/061953 WO2012010478A1 (en) 2010-07-21 2011-07-13 Combination of siloxane and active ingredient for treating dental disorder

Publications (2)

Publication Number Publication Date
JP2013531048A JP2013531048A (ja) 2013-08-01
JP2013531048A5 true JP2013531048A5 (cg-RX-API-DMAC7.html) 2014-08-28

Family

ID=43038027

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013520068A Pending JP2013531048A (ja) 2010-07-21 2011-07-13 歯牙障害を治療するためのシロキサンおよび活性成分の組合せ

Country Status (11)

Country Link
US (1) US20130184239A1 (cg-RX-API-DMAC7.html)
EP (2) EP2409702A1 (cg-RX-API-DMAC7.html)
JP (1) JP2013531048A (cg-RX-API-DMAC7.html)
KR (1) KR20130043203A (cg-RX-API-DMAC7.html)
CN (1) CN103096890A (cg-RX-API-DMAC7.html)
AU (1) AU2011281719A1 (cg-RX-API-DMAC7.html)
BR (1) BR112013001492A2 (cg-RX-API-DMAC7.html)
CA (1) CA2805980A1 (cg-RX-API-DMAC7.html)
MX (1) MX2013000800A (cg-RX-API-DMAC7.html)
RU (1) RU2013107451A (cg-RX-API-DMAC7.html)
WO (1) WO2012010478A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2699371C1 (ru) * 2018-12-06 2019-09-05 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КубГМУ Минздрава России) Стоматологическая паста для временного пломбирования каналов корней зубов при лечении хронического деструктивного периодонтита

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11180841A (ja) * 1997-12-15 1999-07-06 Lion Corp 口腔用組成物
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
JP2001354535A (ja) * 2000-06-13 2001-12-25 Lion Corp 口腔用組成物
JP2002179569A (ja) 2000-12-12 2002-06-26 Lion Corp 口腔用組成物
EP1472263B1 (de) 2001-11-13 2006-08-30 GE Bayer Silicones GmbH & Co. KG Verwendung von siloxanen als verdampfbare träger
EP1443892B1 (en) 2001-11-15 2009-06-10 Laboratorios Miret, S.A. Use of cationic surfactant as antimicrobial activity enhancer in deodorants and oral care
JP2004107310A (ja) * 2002-09-13 2004-04-08 Lion Corp 口腔用組成物
WO2007013175A1 (ja) 2005-07-29 2007-02-01 Takeshi Tanaka 歯用漂白剤
GB0518769D0 (en) 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations

Similar Documents

Publication Publication Date Title
JP2012255026A5 (cg-RX-API-DMAC7.html)
JP2013542247A5 (cg-RX-API-DMAC7.html)
JP2012502037A5 (cg-RX-API-DMAC7.html)
JP2013518107A5 (cg-RX-API-DMAC7.html)
BR112013022044A2 (pt) veículo mastigável para absorção na boca
WO2015120110A3 (en) Novel pharmaceutical formulations
JP2015155440A5 (cg-RX-API-DMAC7.html)
JP2013525444A5 (cg-RX-API-DMAC7.html)
JP2011037901A5 (cg-RX-API-DMAC7.html)
UA114351C2 (uk) Поліциклічні карбамоїлпіридонові сполуки та їх фармацевтичне застосування
JP2013537423A5 (cg-RX-API-DMAC7.html)
SI2709613T1 (en) Procedures for the treatment of HCV
TR201909277T4 (tr) Rasajilinin genişletilmiş salınım formülasyonları ve kullanım alanları.
JP2011527299A5 (cg-RX-API-DMAC7.html)
WO2012098562A3 (en) Liquid oral compositions of lanthanum salts
WO2017083304A8 (en) Therapeutic compositions for treatment of human immunodeficiency virus
JP2014505107A5 (cg-RX-API-DMAC7.html)
EA201490222A1 (ru) Комбинированные составы на основе дарунавира
BR112014000195A2 (pt) formulações de darunavir
MA32841B1 (fr) Composés de cycloundeca depsipeptides et leur utilisation comme médicament
JP2011046708A5 (cg-RX-API-DMAC7.html)
JP2012508256A5 (cg-RX-API-DMAC7.html)
JP2012528856A5 (cg-RX-API-DMAC7.html)
JP2010500284A5 (cg-RX-API-DMAC7.html)
JP2011068692A5 (cg-RX-API-DMAC7.html)